Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Pharmaceutical targeting cancer stem cells in breast cancer

Reference number
Coordinator Cormorant Pharmaceuticals AB
Funding from Vinnova SEK 15 538
Project duration February 2013 - May 2013
Status Completed

Last updated 25 November 2019

Reference number 2013-01091

Page statistics